Skip to main content

and
  1. Article

    Open Access

    Harnessing low dimensionality to visualize the antibody–virus landscape for influenza

    Antibodies constitute a key line of defense against the diverse pathogens we encounter in our lives. Although the interactions between a single antibody and a single virus are routinely characterized in exquis...

    Tal Einav, Adrian Creanga, Sarah F. Andrews in Nature Computational Science (2023)

  2. Article

    Open Access

    Structure-based design of stabilized recombinant influenza neuraminidase tetramers

    Influenza virus neuraminidase (NA) is a major antiviral drug target and has recently reemerged as a key target of antibody-mediated protective immunity. Here we show that recombinant NAs across non-bat subtype...

    Daniel Ellis, Julia Lederhofer, Oliver J. Acton in Nature Communications (2022)

  3. Article

    A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

    Conserved epitopes on the influenza hemagglutinin (HA) stem are an attractive target for universal vaccine strategies as they elicit broadly neutralizing antibodies. Such antibody responses to stem-specific ep...

    Sarah F. Andrews, Julie E. Raab, Jason Gorman, Rebecca A. Gillespie in Nature Medicine (2022)

  4. Article

    Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

    Currently, licensed seasonal influenza vaccines display variable vaccine effectiveness, and there remains a need for novel vaccine platforms capable of inducing broader responses against viral protein domains ...

    Katherine V. Houser, Grace L. Chen, Cristina Carter, Michelle C. Crank in Nature Medicine (2022)

  5. No Access

    Article

    Quadrivalent influenza nanoparticle vaccines induce broad protection

    Influenza vaccines that confer broad and durable protection against diverse viral strains would have a major effect on global health, as they would lessen the need for annual vaccine reformulation and immuniza...

    Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A. Gillespie, Geoffrey B. Hutchinson in Nature (2021)

  6. Article

    Open Access

    A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

    Broadly neutralizing antibodies (bnAbs) have been developed as potential countermeasures for seasonal and pandemic influenza. Deep characterization of these bnAbs and polyclonal sera provides pivotal understan...

    Adrian Creanga, Rebecca A. Gillespie, Brian E. Fisher in Nature Communications (2021)

  7. Article

    Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

    In the version of this article initially published, the labels (50 Å) above the scale bars in Fig. 1b were incorrect. The correct size is 50 nm. The error has been corrected in the HTML and PDF versions of the...

    Masaru Kanekiyo, M. Gordon Joyce, Rebecca A. Gillespie in Nature Immunology (2019)

  8. No Access

    Article

    Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

    The present vaccine against influenza virus has the inevitable risk of antigenic discordance between the vaccine and the circulating strains, which diminishes vaccine efficacy. This necessitates new approaches...

    Masaru Kanekiyo, M. Gordon Joyce, Rebecca A. Gillespie in Nature Immunology (2019)

  9. No Access

    Article

    Prevalence of off-target effects in Drosophila RNA interference screens

    The use of long double-stranded RNAs (dsRNAs) in Drosophila, where Dicer-mediated processing produces small RNAs inside cells, has been thought to reduce the probability of 'off-target effects' (OTEs). However, t...

    Yong Ma, Adrian Creanga, Lawrence Lum, Philip A. Beachy in Nature (2006)